Phase
Condition
Bulimia
Binge Eating Disorder
Treatment
BP1.4979 active drug
Placebo
Clinical Study ID
Ages 18-65 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patient must voluntarily express a willingness to participate in this study, signand date an informed consent prior to beginning any protocol required procedures.
Female aged between 18 and 65 years, inclusive.
Diagnosis of BED according to DSM-5 criteria
BMI < 50 kg/m2.
Exclusion
Exclusion Criteria:
Current diagnosis of bulimia nervosa or anorexia nervosa.
History of bariatric surgery.
Patient who is pregnant, lactating, or of childbearing potential who is not usingadequate contraceptive measures. The following are considered adequate methods ofbirth control: 1. intrauterine device (IUD); 2. barrier protection; 3. contraceptiveimplantation system; 4. oral contraceptive pills; 5. surgically sterile patient; and
- abstinence. All participants should have a negative pregnancy test prior torandomization
- Ongoing alcohol or tobacco addiction treatment (except Nicotine Replacement Therapy [NRT] with at least one-month stable dose prior to screening visit).
Study Design
Study Description
Connect with a study center
Nutrition Department, La Pitié Salpêtrière Hospital
Paris, 75013
FranceSite Not Available
Nutrition Department, La Pitié Salpêtrière Hospital
Paris 2988507, 75013
FranceSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.